Squarepoint’s The Oncology Institute TOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$73.2K Sell
23,831
-37,933
-61% -$116K ﹤0.01% 4111
2025
Q4
$220K Sell
61,764
-80,790
-57% -$300K ﹤0.01% 3805
2025
Q3
$498K Buy
+142,554
New +$488K ﹤0.01% 3238
2024
Q2
Sell
-105,824
Closed -$167K 4653
2024
Q1
$167K Buy
105,824
+8,962
+9% +$17K ﹤0.01% 3670
2023
Q4
$198K Buy
+96,862
New +$168K ﹤0.01% 3600

Other funds holding TOI

Squarepoint's TOI Position: Q1 2026 in Review

Squarepoint reduced its The Oncology Institute (TOI) stake by 61% in Q1 2026, selling an estimated $116K and leaving 23,831 shares worth $73.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4111.

Squarepoint first reported a position in TOI in Q4 2023 and has held it in 5 quarters since. The position peaked at $498K in Q3 2025. 115 funds tracked by Wall St. Rank hold TOI as of Q1 2026.

  • Squarepoint held 23,831 shares of The Oncology Institute worth $73.2K as of Q1 2026.
  • Squarepoint sold 37,933 The Oncology Institute shares in Q1 2026, an estimated $116K.
  • The Oncology Institute made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #4111 holding.
  • Squarepoint first reported a position in The Oncology Institute in Q4 2023 and has held it in 5 quarters since.
  • Squarepoint's The Oncology Institute position peaked at $498K in Q3 2025.
  • 115 funds tracked by Wall St. Rank held The Oncology Institute as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.